BIG 2-04 SUPREMO
The Selective Use of Postoperative Radiotherapy aftEr MastectOmy (SUPREMO) is a randomised phase III trial assessing the role of chest wall irradiation in women with intermediate risk breast cancer following mastectomy.
Coordinating group: National Cancer Research Institute - Breast Cancer Study Group (NCRI-BCSG)
Target nr of patients: 1600
Final nr of patients: 1688
ClinicalTrials.gov identifier: NCT00966888
To learn more, visit: http://www.supremo-trial.com/